目的：探讨紫杉醇联合吉西他滨治疗晚期复发转移性乳腺癌的临床疗效。方法选取32例晚期复发转移性乳腺癌患者，均接受紫杉醇联合吉西他滨治疗，观察患者的临床疗效。结果32例患者中，完全缓解的1例，占3.13%；部分缓解的14例，占43.75%；稳定的12例，占37.5%；疾病进展的5例，占15.63%。有效率为46.88%，疾病控制率为84.38%，中位无进展生存期5.6个月。结论紫杉醇联合吉西他滨治疗晚期复发转移性乳腺癌临床疗效良好好。%Objective Analysis on the efficacy of chemotherapy by Paclitaxel and Gemcitabine in recurrent metastatic breast cance. Methods 32 cases of recurrent metastatic breast cance received Paclitaxel and Gemcitabine. Results CR 3.13%,PR 43.75%,SD 37.5%,PD 15.63%,RR 46.88%,the median progression-free survival was 5.6 months. Conclusion The combined use of Paclitaxel and Gemcitabine is relatively effective for treatment of patients with metastatic breast cancer.
展开▼
